| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.9 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.02 | 0.9 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.0031 | 0.9 |